Childhood Cancer Survivor Study (CCSS) investigators and institutions: Leslie L. Robison, PhD, Melissa Hudson, MD, Greg Armstrong, MD, and Daniel M. Green, MD (St. Jude Children's Research Hospital, Memphis, Tenn); Lillian Meacham, MD and Ann Mertens, PhD (Children's Healthcare of Atlanta/Emory University, Atlanta, Ga); Joanna Perkins, MD and Maura O'Leary, MD (Children's Hospitals and Clinics of Minnesota, St. Paul, Minn); Debra Friedman, MD, MPH and Thomas Pendergrass, MD (Children's Hospital and Medical Center, Seattle, Wash); Brian Greffe, MD and Lorrie Odom, MD (Children's Hospital, Denver, Colo); Kathy Ruccione, RN, MPH (Children's Hospital, Los Angeles, Calif); John Mulvihill, MD (Children's Hospital, Oklahoma City, Okla); Jill Ginsberg, MD and Anna Meadows, MD (Children's Hospital of Philadelphia, Philadelphia, Pa); Jean Tersak, MD, A. Kim Ritchey, MD, and Julie Blatt, MD (Children's Hospital of Pittsburgh, Pittsburgh, Pa); Gregory Reaman, MD and Roger Packer, MD (Children's National Medical Center, Washington, DC); Stella M. Davies, MD, PhD (Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio); Smita Bhatia, MD, MPH (City of Hope, Los Angeles, Calif); Lisa Diller, MD, Holcombe Grier, MD, and Frederick Li, MD (Dana-Farber Cancer Institute/Childrens Hospital, Boston, Mass); Wendy M. Leisenring, ScD and John Potter, MD, PhD (Fred Hutchinson Cancer Research Center, Seattle, Wash); Mark Greenberg, MBChB and Paul C. Nathan, MD (Hospital for Sick Children, Toronto, Ontario); John Boice, ScD (International Epidemiology Institute, Rockville, Md); Vilmarie Rodriguez, MD, W. Anthony Smithson, MD, and Gerald Gilchrist, MD (Mayo Clinic, Rochester, Minn); Charles A. Sklar, MD and Kevin Oeffinger, MD (Memorial Sloan-Kettering Cancer Center, New York, NY); Jerry Finklestein, MD (Miller Children's Hospital, Long Beach, Calif); Roy Wu, PhD and Peter Inskip, ScD (National Cancer Institute, Bethesda, Md); Amanda Termuhlen, MD, Frederick Ruymann, MD, Stephen Qualman, MD, and Sue Hammond, MD (Nationwide Children's Hospital, Columbus, Ohio); Terry A. Vik, MD and Robert Weetman, MD (Riley Hospital for Children, Indianapolis, Ind); Martin Brecher, MD (Roswell Park Cancer Institute, Buffalo, NY); Robert Hayashi, MD and Teresa Vietti, MD (St. Louis Children's Hospital, Mo); Neyssa Marina, MD, Sarah S. Donaldson, MD, and Michael P. Link, MD (Stanford University School of Medicine, Stanford, Calif); Zoann Dreyer, MD (Texas Children's Hospital, Houston, Tex); Kimberly Whelan, MD, MSPH, Jane Sande, MD, and Roger Berkow, MD (University of Alabama, Birmingham, Ala); Yutaka Yasui, PhD (University of Alberta, Edmonton, Alberta); Jacqueline Casillas, MD, MSHS and Lonnie Zeltzer, MD (University of California-Los Angeles, Low Angeles, Calif); Robert Goldsby, MD and Arthur Ablin, MD (University of California-San Francisco, San Francisco, Calif); Raymond Hutchinson, MD (University of Michigan, Ann Arbor, Mich); Joseph Neglia, MD, MPH (University of Minnesota, Minneapolis, Minn); Dennis Deapen, DrPH (University of Southern California, Los Angeles, Calif); Norman Breslow, PhD (University of Washington, Seattle, Wash); Dan Bowers, MD, Gail Tomlinson, MD, and George R. Buchanan, MD (University of Texas Southwestern Medical Center, Dallas, Tex); Louise Strong, MD and Marilyn Stovall, MPH, PhD (University of Texas M. D. Anderson Cancer Center, Houston, Tex).
The CCSS is a collaborative, multi-institutional project, funded as a resource by the National Cancer Institute, of individuals who survived ≥5 years after a diagnosis of childhood cancer. CCSS is a retrospectively ascertained cohort of 20,346 childhood cancer survivors who were diagnosed before age 21 years between 1970 and 1986 and approximately 4000 siblings of survivors who serve as a control group. The cohort was assembled through the efforts of 26 participating clinical research centers in the United States and Canada. The study currently is funded by a U24 resource grant (National Cancer Institute grant U24 CA55727) awarded to St. Jude Children's Research Hospital. Currently, investigators are in the process of expanding the cohort to include an additional 14,000 childhood cancer survivors who were diagnosed before age 21 years between 1987 and 1999. For information on how to access and use the CCSS resource, visit www.stjude.org/ccss